Editas Medicine, Inc. Common Stock EDIT
$2.84
+0.71%
at last close
Analyst Consensus
- Consensus Rating
- Buy (3 Buy · 1 Hold · 0 Sell)
- Average Price Target
- $5.25
- Implied Upside
- +84.9%
- Price Target Range
- $4.00 – $8.00
- Analysts (12 mo)
- 4
Recent Analyst Actions
| Date | Firm | Action | Rating | Price Target |
|---|---|---|---|---|
| 2026-05-05 | Chardan CapitalGeulah Livshits |
Maintains | Buy | $4 → $4 |
| 2026-03-10 | Jones TradingSoumit Roy |
Upgrades | Hold → Buy | $8 |
| 2026-03-09 | Chardan CapitalGeulah Livshits |
Maintains | Buy | $4 |
| 2025-09-05 | HC Wainwright & Co.Mitchell S. Kapoor |
Reiterates | Buy | $5 |
| 2025-09-03 | Wells FargoYanan Zhu |
Maintains | Equal-weight | $3 → $4 |
| 2025-08-15 | HC Wainwright & Co.Mitchell S. Kapoor |
Maintains | Buy | $3 → $5 |
| 2025-08-13 | BairdJoel Beatty |
Maintains | Outperform | $4 → $6 |
| 2025-05-13 | BairdJoel Beatty |
Maintains | Outperform | $8 → $4 |
| 2025-04-28 | HC Wainwright & Co.Mitchell Kapoor |
Initiates coverage on | Buy | $3 |
| 2024-12-16 | Evercore ISI GroupLiisa Bayko |
Maintains | Outperform | $7 → $5 |
| 2024-12-16 | JP MorganBrian Cheng |
Downgrades | Neutral → Underweight | — |
| 2024-12-13 | RBC CapitalLuca Issi |
Maintains | Sector perform | $5 → $4 |
| 2024-12-13 | BarclaysGena Wang |
Maintains | Equal-weight | $5 → $3 |
| 2024-12-13 | Chardan CapitalGeulah Livshits |
Downgrades | Buy → Neutral | — |
| 2024-12-13 | BairdJoel Beatty |
Maintains | Outperform | $10 → $8 |
| 2024-12-13 | StifelDae Gon Ha |
Downgrades | Buy → Hold | $11 → $3 |
| 2024-12-11 | Wells FargoYanan Zhu |
Downgrades | Overweight → Equal-weight | $7 → $4 |
| 2024-11-05 | Chardan CapitalGeulah Livshits |
Maintains | Buy | $12 |
| 2024-11-05 | RBC CapitalLuca Issi |
Maintains | Sector perform | $8 → $5 |
| 2024-11-05 | StifelDae Gon Ha |
Maintains | Buy | $17 → $11 |
| 2024-11-05 | Truist SecuritiesJoon Lee |
Maintains | Buy | $12 → $8 |
| 2024-11-05 | Wells FargoYanan Zhu |
Maintains | Overweight | $9 → $7 |
| 2024-11-05 | BarclaysGena Wang |
Maintains | Equal-weight | $7 → $5 |
| 2024-10-23 | Evercore ISI GroupLiisa Bayko |
Maintains | In-line | $7 → $3 |
| 2024-10-23 | Wells FargoYanan Zhu |
Maintains | Overweight | $27 → $9 |
| 2024-10-22 | Chardan CapitalGeulah Livshits |
Maintains | Buy | $20 → $12 |
| 2024-09-19 | RBC CapitalLuca Issi |
Reiterates | Sector perform | $8 |
| 2024-09-17 | Jones TradingSoumit Roy |
Initiates coverage on | Buy | $13 |
| 2024-08-08 | BarclaysGena Wang |
Maintains | Equal-weight | $9 → $7 |
| 2024-08-08 | Truist SecuritiesJoon Lee |
Maintains | Buy | $20 → $12 |
Ratings and price targets reflect each firm's most recent published action. Consensus combines the latest call from every covering firm over the past 12 months; price targets are typically 12-month horizons.
Key Stats
- Last Close
- $2.84
- Market Cap
- $433.10 million
- 52-Week Range
- $1.66 – $4.54
- Average Volume
- 1.76 million shs
Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.